Oracle’s AI Ambition Meets Financial Headwinds
21.01.2026 - 22:13:04Oracle finds itself at the center of a massive strategic pivot toward artificial intelligence infrastructure. However, the very financing of this ambitious expansion is creating significant turbulence for its stock, despite a colossal order backlog and bullish analyst projections. A billion-dollar bond lawsuit, mounting debt, and geopolitical tensions are colliding with the company's growth narrative.
Operationally, Oracle's performance remains robust. In its most recent quarter, reported on December 10, 2025, the company posted substantial growth:
- Revenue reached $16.1 billion, a 14% year-over-year increase.
- Cloud revenue surged to $8.0 billion, up 34%.
- Cloud infrastructure sales were particularly strong at $4.1 billion, a 68% jump.
- Adjusted earnings per share came in at $2.26, rising 54%.
- Remaining Performance Obligations (RPO) soared to $523 billion, up 438%.
The company maintains a 32% operating margin and generated $21.5 billion in operating cash flow over the trailing twelve months. Furthermore, the board approved a quarterly dividend of $0.50 per share, payable on January 23, 2026. These solid fundamentals stand in stark contrast to recent share price weakness.
Bondholder Lawsuit Shifts Investor Focus
A primary catalyst for the stock's decline is a class-action lawsuit filed by bondholders in New York on January 14. Led by the Ohio Carpenters' Pension Plan, the plaintiffs allege Oracle provided insufficient disclosure during an $18 billion bond issuance in September 2025.
The contention centers on Oracle securing approximately $38 billion in additional loans just seven weeks after the bond placement. These funds are earmarked for new data centers in Texas and Wisconsin, intended to support a five-year, $300 billion contract with OpenAI.
The bondholders argue that the prospectus language stating the company "could" seek more debt was misleading, given that concrete financing plans were allegedly already in place. Defendants include Oracle itself, Executive Chairman Larry Ellison, former CEO Safra Catz, the chief accounting officer, and 16 underwriting banks. This legal action has sharpened investor scrutiny on Oracle's debt levels and potential liability risks.
Debt Burden and Market Reaction
The market's reaction has been pronounced. Shares currently trade around €165.90, marking a decline of roughly 14% from levels seen just a week ago. This price action has pushed the stock below key moving averages, indicating a weakened short-term technical posture.
Underpinning the concern is a significant debt load. As of the end of November 2025, total liabilities stood at approximately $108 billion. Over $100 billion of this is directly or indirectly linked to building out AI data center capacity. This aggressive financing strategy is currently overshadowing even positive metrics like the massive $523 billion cloud backlog.
Should investors sell immediately? Or is it worth buying Oracle?
Guggenheim's Bullish Counterpoint
Despite the sell-off, Guggenheim analyst John DiFucci maintains a highly optimistic outlook. On January 20, he named Oracle his "Top Idea" for 2026, reaffirmed a Buy rating, and set a price target of $400—well above current trading levels.
DiFucci views Oracle as a potential "decades stock" that could evolve into the leading provider of AI infrastructure. His model projects revenue multiplying from an estimated $67 billion in fiscal 2026 to $228 billion by 2030, driven primarily by cloud infrastructure for AI workloads.
The "Bring-Your-Own-Chip" Model and OpenAI Reliance
A cornerstone of DiFucci's analysis is Oracle's "Bring-Your-Own-Chip" (BYOC) model. This approach allows customers to supply their own GPUs into the Oracle Cloud Infrastructure, rather than the company financing all hardware itself. Guggenheim estimates this could reduce Oracle's actual capital requirement to under $100 billion, potentially saving 45% to 65% on AI-related investment costs by lowering upfront hardware financing.
The analyst also addresses the notable concentration in Oracle's order book: roughly 60% of the remaining performance obligations, or about $315 billion, is tied to OpenAI. DiFucci frames this as an endorsement of Oracle's technology, projecting OpenAI-related revenue to grow from an estimated $3.6 billion in fiscal 2026 to $62.4 billion by 2030. He suggests financing for this expansion could come from further capital raises, a potential OpenAI IPO, or increased support from partners like SoftBank.
Geopolitical and Macro Pressures
Adding to company-specific issues, broader macroeconomic headwinds have emerged. Tensions between the U.S. and the EU over political disputes concerning Greenland have stoked fears of a trade conflict. This has prompted many market participants to reduce risk exposure, particularly in globally positioned technology stocks like Oracle, amplifying the downward pressure from the bond lawsuit and debt concerns.
Looking Ahead: Key Milestones by March
The next significant test will be Oracle's third-quarter fiscal 2026 results, expected in March. Analysts currently anticipate earnings per share of $1.71 on revenue of $16.9 billion for the quarter ending in February.
The consensus rating sits at "Moderate Buy," with a median price target near $292, suggesting significant potential upside. However, the wide range of estimates—from $175 to $400—highlights the divergent views on the probable success of Oracle's AI offensive.
In the near term, investors will monitor three critical factors: progress on constructing new data centers, the pace at which the enormous backlog converts to recognized revenue, and any developments in the bondholder lawsuit. How these elements evolve by the March reporting date will likely determine whether the current weakness is remembered as an exaggerated downturn or a justified warning signal.
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from January 21 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 21.
Oracle: Buy or sell? Read more here...


